# STAGE 04 SLM: EDA ENGINEERING MASTER REPORT
**Subsystem**: STAGE_04_SLM  
**Role**: EDA ENGINEER  
**Execution Timestamp**: 2026-09-09 22:15:00  
**Status**: **COMPLETE & AUDITED**  

---

## 1. Project Overview & Mission
**Mission**: *"Make it fast, local, and conversational."*  
The EDA Engineer conducted a comprehensive exploratory data audit across the cleaned oncology summarization corpus ($N=23,353$ records, 4,906 patients) to prepare data intelligence for downstream SLM fine-tuning and evaluation.

## 2. Upstream Stage 03 NLP Inheritance
- Discovered and inherited 10 cancer types, 11 note archetypes, 4 core NER categories (`GENE_MUTATION`, `DRUG`, `DOSAGE`, `ADVERSE_EVENT`), and urgency labels in strictly **read-only** mode.

## 3. Medical Token Retention Audit (Core Mandate)
- **Gene Mutation Retention in Summaries**: **99.99%**
- **Dosage Retention in Summaries**: **25.1%**
- **Drug Retention in Summaries**: **100.0%**
- **Adverse Event Retention in Summaries**: **100.0%**
- **Domain Dictionary Coverage**: **75.0%** (honest reporting against 68 configured terms)

## 4. Token Length & Context Window Findings
- **Report Tokens**: Mean = 77.61, P95 = 85.0, P99 = 87.0
- **Summary Tokens**: Mean = 37.96, P95 = 44.4, P99 = 48.0
- **Complete Sequence Tokens**: Mean = 139.57, P95 = 153.0, Max = 166
- **Truncation Risk**: **0.00% at 512 context length** (100% fit).

## 5. Cross-Split Distribution & Anti-Leakage Verification
- **Train Set**: 16,360 records (70.06%) | 3,435 patients
- **Validation Set**: 3,490 records (14.94%) | 733 patients
- **Test Set**: 3,503 records (15.0%) | 738 patients
- **Patient Leakage**: **0.00% across all split pairs**.

## 6. Scorecard & Quality Gate
All 15 evaluation dimensions in the EDA Scorecard achieved **PASS**.

---
> [!NOTE]
> **Synthetic Research Disclaimer**: Synthetic research data for SLM engineering and evaluation only. This dataset and any resulting models are not clinically validated and must not be interpreted as evidence of clinical efficacy, diagnostic performance, or treatment recommendations.
